flatulence
Acalypha alopecuroidea(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaves, decoction with salt, taken orally1-2 |
Recommandations
Preparation and posology References |
According to published and other information: Use for flatulence is classified as REC, based on the significant traditional uses documented in TRAMIL surveys, toxicity studies, and published scientific information. Not for use in children under 5 years of age, or pregnant or lactating women. Do not consume for more than 3 days in a row. |
Use for flatulence: Prepare a decoction with 30 grams of leaves in 1 liter (4 cups) of water, boil uncovered for at least 10 minutes. Cool, filter, and drink one cup after meals. |
1 WENIGER B, ROUZIER M, 1986 2 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 3 WENIGER B, SAVARY H, DAGUIHL R, 1984 4 HEGNAUER R, 1973 5 HOSTETTMANN K, LEA P, Eds., 1987 6DEL ROSARIO PEREZ R, WENIGER B, 1988 7 MORON F, BETANCOURT J, PINEDO Z, BOUCOURT E, 2000 8 LE GRAND A, WONDERGEM PA, 1986 9SOUZA BRITO A, 1995 10 MARTINEZ MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BARCELO H, LAINEZ A, MONTES ME, REGO R, BOUCOURT E, MORON F, 2000 11MARTINEZ MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BARCELO H, LAINEZ A, MONTES ME, REGO R, BOUCOURT E, MORON F, 2000 12 POULTON J, KEELER R, TU T, Eds., 1983 13 NAHRSTEDT A, 1987 14 ARGEHEORE EM, AGUNBIADE OO, 1991 |
||
Allium sativum(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys bulb, decoction, taken orally1-6,74,75 |
Recommandations
Preparation and posology References |
Use for “bad blood” is a traditional cultural use of our communities and is not classified in the TRAMIL Program. According to published and other information: Use for skin conditions, pruritus, candidiasis, gastric bloating, nausea, flatulence, and intestinal parasites is classified as REC, based on significant traditional use documented in the TRAMIL surveys and published scientific information. Use for toothaches, earaches, and fever is classified as REC, based on significant traditional uses (OMS/WHO)7 documented by TRAMIL surveys. The bulb can cause reactions of hypersensitivity. For topical application, strict hygiene measures should be observed in order to avoid contamination or additional infection. Due to the possibility that an earache could signal a middle or inner ear infection, immediate medical evaluation is recommended. Do not use if there are secretions from the ear and/or possible perforation of the eardrum. If the patient’s condition worsens or if the earache persists for more than 2 days, seek medical attention. Contraindicated for use in hyperthyroidism8. The extracts from garlic interact with anticoagulant, antihypertensive and antidiabetic treatments. |
The bulb of Allium sativum is widely used for human consumption. The garlic bulb for medicinal purposes should be taken together with meals, so as to prevent gastro-intestinal problems71. For fever, gastric bloating, nausea, flatulence and intestinal parasites: Prepare a decoction with 2 to 5 grams of fresh garlic71 (1 to 2.5 cloves) or 2 to 4 grams of dried garlic71 in 1 cup of water (250 mL), boil for at least 10 minutes in a covered pot. Cool and drink 1 cup 3 times a day. For other forms of administration of garlic bulb, the daily consumption doses recommended by OMS71 are: for oil: 2 to 5 mg; for extracts, 300 to 1000 mg (as solid material). Other type of pharmaceutical preparations should meet alliine values of 4-12 mg or allicine values of 2-5 mg71. For treatment of skin conditions, pruritus, candidiasis, toothache, and earache: 2 to 5 g (1 to 2.5 cloves) of peeled fresh garlic; wash thoroughly and crush, then apply to the affected area twice a day. |
1 WENIGER B, ROUZIER M, 1986 2 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 3 GIRON L, 1988 4 WENIGER B, 1987-88 5 JEAN-PIERRE L, 1988 6 FAUJOUR A, MURREY D, CHELTENHAM-CORBIN B, CARRINGTON S, 2003 7 WHO, 1991 8 ARTECHI A (Ed.), 1998 9 SENDL A, ELBL G, STEINKE B, REDL K, BREU W, WAGNER H, 1992 10 CALVEY EM, ROACH JAG, BLOCK E, 1994 11 BLOCK E, AHMAD S, CATALFAMO JL, JAIN MK, APITZ-CASTRO R, 1986 12 MOCHIZUKI E, YAMAMOTO T, KOMIYAMA Y, NAKAZAWA H, 1998 13 UEDA Y, SAKAGUCHI M, HIRAYAMA K, MIYAJIMA R, KIMIZUKA A, 1990 14 KOCH HP, JAGER W, 1989 15 LAWSON LD, WANG ZYJ, HUGHES BG, 1991 16 OHSUMI C, HAYASHI T, KUBOTA K, KOBAYASHI A, 1993 17 LAWSON LD, WOOD SG, HUGHES BG, 1991 18 MUTSCH-ECKNER M, ERDELMEIER CAJ, STICHER O, REUTER HD, 1993 19 INAGAKI M, HARADA Y, YAMADA K, ISOBE R, HIGUCHI R, MATSUURA H, ITAKURA Y, 1998 20 AL-NAGDY SA, ABDEL-RAHMAN MO, HEIBA HI, 1988 21 ROLLERI F, 1943 22 RAKHIMBAEV IR, OL'SHANSKAYA RV, 1981 23 KOCH HP, JAGER W, GROH U, HOVIE JE, PLANK G, SEDLAK U, PRAZNIK W, 1993 24 BAUMGARTNER S, DAX TG, PRAZNIK W, FALK H, 2000 25 PENG JP, CHEN H, QIAO YQ, MA LR, NARUI T, SUZUKI H, OKUYAMA T, KOBAYASHI H, 1996 26 MATSUURA H, USHIROGUCHI T, ITAKURA Y, FUWA T, 1989 27 DUKE JA, ATCHLEY AA, 1986 28 DAS I, KHAN N, SOORANA S, 1995 29 KABELIK J, 1970 30 ADETUMBI M, JAVOR G, LAN B, 1986 31 TSAI Y, COLE LL, DAVIS LE, LOCKWOOD SJ, SIMMONS V, WILD GC, 1985 32 SHARMA V, SETHI M, KUMAR A, RAROTRA JR, 1977 33 FROMTLING R, BULMER G, 1978 34 GRAHAM H, GRAHAM E, 1987 35 MOLINA NM, 1992 36 EL-TANBOULY ND, ABDEL-MEGID RM, 1994 37 CACERES A, GIRON L, ALVARADO S, TORRES M, 1987 38 KIUCHI ,F, NAKAMURA N, MIYASHITA N, NISHIZAWA S, TSUDA Y, KONDO K, 1989 39 CHOWDHURY A, AHSAN M, ISLAM SK, AHMED ZU, 1991 40 STANDEN O, 1953 41 TAKASUGI N, KOTOO K, FUWA T, SAITO H, 1984 42 PRASAD DN, BHATTACHARYA SK, DAS PK, 1966 43 BHAKUNI D, DHAR ML, DHAR MM, DHAWAN B, MEHROTRA B, 1971 44 AUGUSTI K, MATHEW P, 1973 45 HIKINO H, TOHKIN M, KISO Y, NAMIKI T, NISHIMURA S, TAKEYAMA K, 1986 46 SHARAF A, 1969 47 PRASAD G, SHARMA V, KUMAR A, 1982 48 TUTAKNE M, BHARDWAJ J, SATYANARAYANAN G, SETHI Y, 1983 49 DELAHA E, GARAGUSI V, 1985 50 PETKOV V, 1966 51 FOUSHEE D, RUFFIN J, BANERJEE U, 1982 52 PARIS R, MOYSE H, 1981 53 RIBEIRO R, BARROS F, MARGARIDA M, MELO R, MUNIZ C, CHIEIA S, WANDERLEY M, GOMES C, TROLIN G, 1988. 54 SPADA C, HOSHIKAWA-FUJIMURA AY, 2001 55 CHUTANI SK, BORDIA A, 1981 56 DAMRAU F, FERGUSON E, 1949 57 YU WC, BLOT WJ, CHANG YS, ERSHOW A, ZT YANG, AN Q, FRAUMENI JR JF, WANG TG, 1989 58 FERNANDEZ EJ, 1995 59 ALONSO JR, 1998 60 DURAFFOURD C, D'HERVICOURT L, LAPRAZ JC, 1994 61 CHAUHAN L, GARG J, BEDI H, GUPT R, BOMB B, AGARWAL M, 1982 62 KANEZAWA A, NAKAGAWA S, SUMIYOSHI H, MASAMOTO K, HARADA H, NAKAGAMI S, DATE S, YOKOTA A, NISHIKAWA M, FUWA T, 1984 63 SUMIYOSHI H, KANEZAWA A, MASAMOTO K, HARADA H, NAKAGAMI S, YOKOTA A, NISHIKAWA M, NAKAGAWA S, 1984 64 AL-BEKAIRI AM, SHAH AH, QURESHI S, 1990 65 HUH K, PARK JM, LEE S-IL, 1985 66 GARNIER G, BEZANGER-BEAUQUESNE L, 1961 67 BOJS G, SVENSSON A, 1988 68 PAPAGEORGION C, CORBET JP, BRANDAO FM, PECEGUEIRO M, BENEZIA C, 1983. 69 CAPORASO N, SMITH S, ENG R, 1983 70 SITPRIJA S, PLENGVIDHYA C, KANGKAYA V, BHUVAPANICH S, TUNKAYOON M, 1987. 71 WHO, 2004 72 MARTINEZ MJ, MOREJON Z, LOPEZ M, BOUCOURT E, FUENTES V, MORON F, 2005 73 MARTINEZ MJ, MOREJON Z, LOPEZ M, BOUCOURT E, FUENTES V, MORON F, 2005 74 BOULOGNE Isabelle, 2008 75 LONGUEFOSSE JL, NOSSIN E, 1990-95 |
||
Anethum graveolens(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys seed, decoction, taken orally1 |
Recommandations
Preparation and posology References |
For both uses, it is mainly described in association with Eupatorium aromatizans, Lippia micromera or salt. According to published and other information: Use for abdominal pain, flatulence and stomach pain is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, and on available published scientific information. Not for use in women intending to procreate, during pregnancy, during lactation or in children under 5 years old. Should there be a notable worsening of the patient’s condition, or should the abdominal or stomach pain last more than 3 days, seek medical attention. |
The aerial parts ofAnethum graveolens are widely used as a spice. For abdominal pain, flatulence and stomach pain: Prepare a decoction with 15-30 grams (2-3 spoonfuls) of seed in one liter (4 cups) of water; boil for 10 minutes minimum in a covered pot. Filter and take one cup after meals24.
|
1 GERMOSÉN-ROBINEAU L, GERÓNIMO M, AMPARO C, 1984 2 HARBONE J, WILLIAMS C, 1972 3 DANIEL M, 1989 4 VARNAITE R, 1988 5 DRANIK LI, PROKOPENKO AP, 1969 6 APLIN RT, PAGE CB, 1967 7 PUNDARIKAKSHUDU K, BHAVSAR G, 1991 8 PINKAS M, BEZANGER-BEAUQUESNE L, 1986 9 DUKE JA, ATCHLEY AA, 1986 1O IKRAM M, HAQ I, 1980 11 KIUCHI F, NAKAMURA N, MIYASHITA N, NISHIZAWA S, TSUDA Y, KONDO K, 1989 12 DHAR ML, DHAR MM, DHAWAN BN, MEHROTRA BN, RAY C, 1968 13 LOREA PAGANINI F, SILVEIRA SN, AMARANTE SILVA F, VENSKE DE ALMEIRA TR, SINNOTT SILVA E, 1992 14 FEIZ J, MOATTAR F, 1985 15 CHANG I, WOO W, 1980 16 PDR Herbal, 2000 17 CANIGUERAL S, VILA R, RISCO E, PEREZ F, PORTILLO A, FREIXA B, MILO B, VANACLOCHA B, RIOS JL, MORALES MA, ALONSO JR, BACHILLER LI, PERIS JB, STUBING G, 2002 18 HARRIES N, JAMES KC, PUGH WK, 1978 19 SHIPOCHLIEV T, 1968 20 DUKE JA, 1992 21 NATAQUE K, KANZAWA K, MIZUNO M, UENO N, KOBAYASHI T, DANNE GI, MINAMOTO S, 1989 22 SETHI N, NATH D, SINGH RK, 1989 23 FUKUOKA M, YOSHIHIRA K, NATORI S, SAKAMOTO K, IWAHARA S, HOSAKA S, IRONO I, 1980 24 ALBORNOZ A, 1993 25 MARTINEZ MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BARCELO H, LAINEZ A, MONTES ME, REGO R, BOUCOURT E, MORON F, 2000 26 LONGUEFOSSE JL, NOSSIN E, 1990-95 |
||
Citrus aurantium(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys fruit peel, infusion, orally5 |
Recommandations
Preparation and posology References |
According to published and other information: Use for colic, conjunctivitis, headache, fever, flu, intestinal parasites and cough is classified as REC, based on the significant traditional use (OMS/WHO)4 documented in the TRAMIL surveys. In every application in the eyes, strict hygiene measures should be observed in order to avoid contamination or additional infection. Additionally, contact with any substances that may be irritating to the conjunctiva should be avoided. There exists the risk of increasing irritation due to the application of Citrus spp juice. Should there be a notable worsening of the patient’s condition, or should fever last more than 2 days, or should conjunctivitis or headache last more than 3 days, seek medical attention. Use for diarrhea and flatulence is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, and on available published scientific information. In the case of diarrhea, the use of this resource can be considered complementary to oral re-hydration therapy. Should there be a notable worsening of the patient’s condition, or should diarrhea last more than 3 days in adult, or 2 days in children, seek medical attention. Due to the risk of interaction with cyclosporin, ingestion of the fruit decoction should be avoided by anyone taking this medicine. The essential oil of the plant can cause reactions of hypersensitivity. |
The fruit and the juice of Citrus aurantium are widely used for human consumption and the peel as an industrial source of essential oil. For colic, headache, fever, flu: Prepare a decoction or infusion with 10-15 grams (3-5 tender leaves) in 1/2 liter (2 cups) of water. For decoction, boil for at least 10 minutes in a covered pot; for infusion, add boiling water to 3-5 tender leaves, cover and leave to cool down. Drink lukewarm, 1 cup 3 times a day1. For fever: Prepare a decoction with 1-2 teaspoonfuls (5-10 grams) of fruit peel in 250 mL (1 cup) of water, boil for at least 10 minutes in a covered pot. Filter, cool down and drink 1 cup 3 times a day33. For flatulence: Prepare an infusion, adding 1 liter (4 cups) of boiling water to the peel of half a fruit. Cover the pot, let it settle for 5-10 minutes and filter. Drink 1 cup as needed5. For intestinal parasites: Prepare a decoction with 8-18 tender leaves in 1/2 liter (2 cups) of water. Boil for at least 10 minutes in a covered pot. Leave it to cool down, sweeten with honey and drink lukewarm, 1 cup twice a day1. For conjunctivitis, diarrhea, flu, cough (juice): There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. |
1 MENDEZ M, MEDINA ML, DURAN R, 1996 Encuesta TRAMIL. Unidad de recursos naturales, Centro de Investigación Científica de Yucatán CICY, Mérida, México. 2 WENIGER B, ROUZIER M, 1986 Enquête TRAMIL. Service Oecuménique d'Entraide SOE, Port au Prince, Haïti. 3 WENIGER B, 1987-88 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 4 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 5 MARCELLE G, 1996 TRAMIL survey. Produce chemist laboratory, Ministry of Agriculture, St George's, Grenada. 6 BENEDETTI MD, 1994 Encuesta TRAMIL. Universidad de Puerto Rico, Mayagüez, Puerto Rico. 7 OMS/WHO, 1991 Pautas para la evaluación de medicamentos herbarios WHO/TRM/91.4 (original inglés). Programa de Medicina Tradicional, OMS, Ginebra, Suiza. 8 LIN Z, HUA Y, GU Y, 1986 The chemical constituents of the essential oil from the flowers, leaves and peels of Citrus aurantium. Chih Wu Hsueh Pao 28(6):635-640. 9 RIO JAD, BENAVENTE O, CASTILLO J, BORREGO F, 1992 Neodiosmin, a flavone glycoside of Citrus aurantium. Phytochemistry 31(2):723-724. 10 BENNETT RD, MIYAKE M, OZAKI Y, HASEGAWA S, 1991 Limonoid glucosides in Citrus aurantium.Phytochemistry 30(11):3803-3805. 11 WIDMER WW, 1991 Improvements in the quantitation of limonin in Citrus juice by reversed-phase high-performance liquid chromatography. J Agric Food Chem 39(8):1472-1476. 12 HERMAN Z, FONG CH, OU P, HASEGAWA S, 1990 Limonoid glucosides in orange juices by HPLC. J Agric Food Chem 38(9):1860-1861. 13 HOSODA K, NOGUCHI M, KANAYA T, HIGUCHI M,1990 Studies on the preparation and evaluation of Kijitsu, the immature citrus fruits. III. Relation between diameter of Kijitsu and synephrine content. Yakugaku Zasshi 110(1):82-84. 14 BEZANGER-BEAUQUESNE L, PINKAS M, TORCK M, 1986 Les plantes dans la thérapeutique moderne. 2 éd. Paris, France: Ed. Maloine. 15 WAGNER H, BLADT S, MUNZING-VASITIAN K, 1975 Thin-layer chromatography of bitter principle drugs. Pharm-Ztg 120:1262. 16 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants. Boca Raton, USA: CRC Press, p45. 17 AVIRUTANT W, PONGPAL A, 1983 The antimicrobial activity of some Thai flowers and plants. Mahidol Univ J Pharm Sci 10(3):81-86. 18 CACERES A, GIRON LM, ALVARADO SR, TORRES MF, 1987 Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases. J Ethnopharmacol 20(3):223-237. 19 KIM DH, SONG MJ, BAE EA, HAN MJ, 2000 Inhibitory effect of herbal medicines on rotavirus infectivity. Biol Pharm Bull 23(3):356-358. 20 SANKAWA U, 1980 Screening of bioactive compounds in oriental medicinal drugs. Korean J Pharmacog 11:125-132. 21 KINOSHITA T, SAMESHIMA M, SANKAWA U, 1979 Isolation of a sympathomimetic substance from Chinese medicinal drugs originated from Citrus sp. Shoyakugaku Zassmi 33:146-149. 22 FORSTER HB, NIKLAS H, LUTZ S, 1980 Antispasmodic effects of some medicinal plants. Planta Med 40(4):309-319. 23 YOO JS, JUNG JS, LEE TH, SON KH, SUH HW, SONG DK, KIM YH, 1995 Inhibitory effects of extracts from traditional herbal drugs on 5-hydroxytryptophan-induced diarrhea in mice. Korean J Pharmacog 26(4):355-359. 24 IWAMA H, AMAGAYA S, OGIHARA Y, 1986 Effects of five kampohozais on the mitogenic activity of lipopolysaccharide, concanavalin A, phorbol myristate acetate and phytohemagglutinin in vivo. J Ethnopharmacol 18(2):193-204. 25 HIRANO H, TAKASE H, YAMAMOTO K, YANASE T, ABE K, SAITO Y, 1997 The anti-ulcer effects of Aurantii Fructus Immaturus, Aurantii Fructus and the principles in Aurantii Fructus Immaturus. Nat Med 51(3):190-193. 26 AZUMA S, YADA Y, IMOKAWA G, TAZAKI S, SHINHO T, 1996 Skin-lightening cosmetics containing plant extracts and ascorbic acid or placenta extracts. Patent-Japan Kokai Tokyo Koho-08 208,451. 27 AMEER B, WEINTRAUB RA, JOHNSON JV, YOST RA, ROUSEFF RL, 1996 Flavonone absorption after naringin, hesperidin, and Citrus administration. Clin Pharmacol Ther 60(1):34-40. 28HARTMAN JG, LIMBIRD ILE, Eds., 1996 Goodman & Gilman las bases farmacológicas de la Terapéutica, 9a edición. México, México: McGraw-Hill Editorial. p1670-1671. 29 HOU YC, HSIU SL, TSAO CW, WANG YH, CHAO PD, 2000 Acute intoxication of cyclosporin caused by coadministration of decoctions of the fruits of Citrus aurantium and the pericarps of Citrus grandis.Planta Med 66(7):653-655. 30 SATO A, 1989 Studies on anti-tumor activity of crude drugs. I. The effects of aqueous extracts of some crude drugs in short term screening test. Yakugaku Zasshi 109(6):407-423. 31 YAMAMOTO H, MIZUTANI T, NOMURA H, 1982 Studies on the mutagenicity of crude drug extracts. I. Yakugaku Zasshi 102(6):596-601. 32 MORIMOTO I, WATANABE F, OSAWA T, OKITSU T, KADA T, 1982 Mutagenicity screening of crude drugs with Bacillus subtilis REC-assay and Salmonella microsome reversion assay. Mutat Res 97(2):81-102. 33 CANIGUERAL S, VILA R, RISCO E, PEREZ F, PORTILLO A, FREIXA B, MILO B, VANACLOCHA B, RIOS JL, MORALES MA, ALONSO JR, BACHILLER LI, PERIS JB, STUBING G, 2002 Citrus aurantium. Vademecum de Fitoterapia, Editorial Masson, Barcelona, España, Jul.20,2002. URL: http://www.masson.es/book/fitoterapia.html 34 MARTINEZ MJ, MOREJON Z, LOPEZ M, BOUCOURT E, FUENTES V, MORON F, 2005 Clases tóxicas agudas (CTA) de una infusión de corteza de fruto fresco de Citrus aurantium L.Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 35 MARTINEZ MJ, MOREJON Z, LOPEZ M, BOUCOURT E, FUENTES V, MORON F, 2005 Clases tóxicas agudas (CTA) de zumo de fruto fresco de Citrus aurantium L.Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 36 GarcIa-GONZALEZ M, fallas LV, 2005 Toxicidad aguda dosis repetida, en ratones, del extracto acuoso (decocción) de las hojas frescas de Citrus aurantium . Informe TRAMIL.PRONAPLAMED. Depto de Fisiología, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 37 MORON FJ, MOREJON Z, GARCIA AI, LOPEZ M, BOUCOURT E, BACALLAO Y, FUENTES V, 2008 Acción analgésica de la decocción 30% de hojas frescas de Citrus aurantium L. (naranja agria) en ratones. Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, Ciudad de La Habana, Cuba. 38 PAZOS L, COTO T, CAIZA F, 2009 Irritación ocular, en conejos, del jugo fresco del fruto de Citrus aurantium. Informe TRAMIL. Laboratorio de Ensayos Biológicos, LEBi, Universidad de Costa Rica, San Pedro, Costa Rica. 39 LONGUEFOSSE JL, NOSSIN E, 1990-95 Enquête TRAMIL. Association pour la valorisation des plantes médicinales de la Caraïbe AVPMC, Fort de France, Martinique. 40 MOREJON Z, LOPEZ M, GARCIA MJ, BOUCOURT E, VICTORIA M, FUENTES V, MORON F, BOULOGNE I, ROBINEAU L, 2009 Encuesta TRAMIL preliminar a grupos de vecinos en los municipios 10 de Octubre, Lisa, Marianao, Habana del Este (Cojímar) en la Ciudad de la Habana. Laboratorio Central de Farmacología, Universidad de Ciencias Médicas de La Habana, Ciudad de La Habana, Cuba. |
||
Cymbopogon citratus(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf, decoction or infusion, orally3 |
Recommandations
Preparation and posology References |
According to published and other information: Use for diarrhea, stomach pain, fever, flatulence, flu, colds and cough is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies, scientific validation and available published scientific information. In case of diarrhea, the use of this resource can be considered complementary to oral re-hydration therapy. Should there be a notable worsening of the patient’s condition, or should diarrhea last more than 3 days in adult or 2 days in children, or should fever last more than 2 days, stomach pain more than 3, or cough more than 5, seek medical attention. Not for use during pregnancy, during lactation or by children under 3 years old. |
TRAMIL Research42 For diarrhea, stomach pain, fever, flatulence, flu, colds and cough: Prepare a decoction or infusion with 15-25 grams of leaf in 1 liter (4 cups) of water. For decoction, boil for at least10 minutes in a covered pot; for infusion, add boiling water to 15-25 grams of leaf. Cover and leave to cool down. Filter and drink 1 cup (250 mL), 2-3 times a day. In all the above-mentioned uses for oral administration, the preparation should be properly filtered, using a cloth, as a prerequisite for consumption, in order to avoid mechanical injuries to the mucosas, due to the microfilaments present in the leaf26. |
1 LAGOS-WITTE S, 1988-89, 1996 Encuesta TRAMIL. Laboratorio de Histología Vegetal y Etnobotánica, Dep. de Biología, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 2 WENIGER B, ROUZIER M, 1986 Enquête TRAMIL. Service Oecuménique d'Entraide SOE, Port au Prince, Haïti. 3 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala, Guatemala. 4 CHARLES C, 1988 TRAMIL survey. Movement for Cultural Awareness MCA, Roseau, Dominica. 5 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 6 JEAN-PIERRE L, 1988 TRAMIL survey. St. Lucia National Herbarium, Castries, St. Lucia. 7 FAUJOUR A, MURREY D, CHELTENHAM-CORBIN B, CARRINGTON S, 2003 TRAMIL survey. enda-caribbean, IICA & UAG, Saint Thomas, Barbados. 8 OCAMPO R, 1988 Encuesta TRAMIL (Costa atlántica), Instituto de Desarrollo Agrario, Universidad de Costa Rica, San José, Costa Rica. 9 LONGUEFOSSE JL, NOSSIN E, 1990-95 Enquête TRAMIL. Association pour la valorisation des plantes médicinales de la Caraïbe AVPMC, Fort de France, Martinique. 10 DELENS M, 1992 Encuesta TRAMIL en los Estados Lara y Sucre de Venezuela. Centro al Servicio de la Acción Popular CESAP, Caracas, Venezuela. 11 O'REILLY A, 1992 TRAMIL survey. Chemistry & Food Technology Division, Ministry of Agriculture, Dunbars, Antigua & Barbuda. 12 BENEDETTI MD, 1994 Encuesta TRAMIL. Universidad de Puerto Rico, Mayagüez, Puerto Rico. 13 MENDEZ M, MEDINA ML, DURAN R, 1996 Encuesta TRAMIL. Unidad de recursos naturales, Centro de Investigación Científica de Yucatán CICY, Mérida, México. 14 BALLAND V, GLASGOW A, SPRINGER F, GAYMES G, 2004 TRAMIL survey. IICA, UAG & U.PARIS XI, Saint Vincent. 15 ABEGAZ B, YOHANNES P, DIETER R, 1983 Constituents of the essential oil of Ethiopian Cymbopogon citratus. J Nat Prod 46(3):424-426. 16 DE MATOUSCHEK B, STAHL-BISKUP E, 1991 Phytochemical investigation of nonvolatile constituents ofCymbopogon citratus (DC.) Stapf. (Poaceae). Pharm Acta Helv 66(9/10):242-245. 17 HANSON S, CRAWFORD M, KOKER M, MENEZES F, 1976 Cymbopogonol, a new triterpenoid from Cymbopogon citratus. Phytochemistry15:1074-1075. 18 YOKOYAMA Y, TSUYUKI T, NAKAMURA N, TAKAHASHI T, HANSON S, MATSUSHITA K, 1980 Revised structures of cymbopogone and cymbopogonol. Tetrahedron Lett21:3701-3702. 19 OLANIYI A, SOFOWORA E, OGUNTIMEHIN B, 1975 Phytochemical investigation of some Nigerian plants used against fevers. II. Cymbopogon citratus. Planta Med 28:186-189. 20 WILLAMAN JJ, LI H, 1970 Alkaloid-bearing plants and their contained alkaloids, 1957-1968. Lloydia33(Supp.3A):1-286. 21 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants. Boca Raton, USA: CRC Press. p57. 22 SAUVAIN M, MORETTI C, MUÑOZ V, 1990 Pruebas in vivo para paludismo realizadas en Bolivia sobre varias plantas TRAMIL. ORSTOM/IRD/IBBA, La Paz, Bolivia. 23 MORON F, SANCHEZ C, MARTINEZ MC, MOREJON Z, PINEDO Z, 2000 Actividad antiespasmódica in vitro de hojas frescas de Cymbopogon citratus (DC.) Stapf. Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 24 MORON F, FURONES J, PINEDO Z, 1996 Ausencia de efectos antiinflamatorio y analgésico del extracto fluído de Cymbopogon citratus al 30% por vía oral. Rev Cubana Plant Med 1(2):3-6. 25 CARBALLO A, 1995 Plantas medicinales del Escambray cubano. Informe TRAMIL. Laboratorio provincial de producción de medicamentos, Sancti Spiritus, Cuba. 26 WENIGER B, ROUZIER M, DAGUILH R, HENRYS D, HENRYS J, ANTON R, 1986 Popular medicine of the central plateau of Haiti. 2. Ethnopharmacological inventory. J Ethnopharmacol 17(1):13-30. 27 CARLINI EA, CONTAR JD, SILVA-FILHO AR, SOLVEIRA-FILHO NG, FROCHTENGARTEN ML, BUENO OF, 1986 Pharmacology of lemon-grass Cymbopogon citratus I. Effect of teas prepared from the leaves on laboratory animals. J Ethnopharmacol 17(1):37-64. 28 SOUZA FORMIGONI ML, LODDER HM, FILHO OG, FERREIRA TM, CARLINI EA, 1986 Pharmacology of lemongrass (Cymbopogon citratus Stapf). II. Effects of daily two month administration in male and female rats and in offspring exposed "in utero". J Ethnopharmacol 17(1):65-74. 29 CARBAJAL D, CASACO A, ARRUZAZABALA L, GONZALEZ R, TOLON Z, 1989 Pharmacological study of Cymbopogon citratus leaves. J Ethnopharmacol25(1):103-107. 30 LAM L, ZHENG B, 1991 Effects of essential oils on glutathione S-transferase activity in mice. J Agric Food Chem 39(4):660-662. 31 LORENZETTI B, SOUZA G, SARTI S, FILHO DS, FERREIRA SH, 1991 Myrcene mimics the peripheral analgesic activity of lemongrass tea. J Ethnopharmacol 34(1):43-48. 32 LEMOS TLG, MATOS FJA, ALENCAR JW, CRAVEIRO AA, CLARK AM, MC CHESNEY JD, 1990 Antimicrobial activity of essential oils of Brazilian plants. Phytother Res4(2):82-84. 33 AWUAH R, 1989 Fungitoxic effects of extracts from some West African plants. Ann Appl Biol 115(3):451-453. 34 REYNOLDS JEF, PRASAD AB, Eds., 1982 MARTINDALE The extra pharmacopoeia. 28th ed. London, England: The Pharmaceutical Press. p677. 35 SETH, G, KOKATE CK, VARMA KC, 1976 Effect of essential oil of Cymbopogon citratus on central nervous system. Indian J Exp Biol 14(3):370-371. 36 DUKE JA, 1992 Handbook of biologically active phytochemicals and their bioactivities. Boca Raton, USA: CRC Press. 37 KOBAYASHI N, 1989 Pharmaceutical compositions containing lemongrass extracts and antioxidants. Patens Japan Kokai Tokio Koho., 01, 221, 320. 38 MARTINEZ MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BARCELO H, LAINEZ A, MONTES ME, REGO R, BOUCOURT E, MORON F, 2000 Toxicidad aguda clásica de hoja seca de Cymbopogon citratus (DC.) Stapf.Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 39 MARTINEZ MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BOUCOURT E, MORON F, 2000 Actividad genotóxica in vitro de hoja seca de Cymbopogon citratus (DC.) Stapf. Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 40 de la Torre RA, Espinosa-Aguirre JJ, Cortinas de Nava C, Izquierdo T, Moron F, 1994 Genotoxic activity of mebendazole in Aspergillus nidulans. Mutat Res 305(2):139-144. 41 LEITE JR, SEABRA ML, MALUF E, ASSOLANT K, SUCHECKI D, TUFIK S, KLEPACZ S, CALIL HM, CARLINI EA, 1986 Pharmacology of lemongrass (Cymbopogon citrates Stapf). III. Assessment of eventual toxic, hypnotic and anxiolytic effects on humans. J Ethnopharmacol 17(1):75-83. 42 CARBALLO A, 1995 Cálculo de concentración y dosis de las drogas vegetales TRAMIL: Mensuraciones farmacognósticas y aproximaciones técnico-clínicas. Laboratorio provincial de producción de medicamentos, Sancti Spiritus, Cuba. 43 DELAIGUE J, 2005 TRAMIL survey. UAG & PRDI, Tobago House of Assembly, Scarborough, Tobago. 44 ZambranoLE, 2007 Encuesta TRAMIL en Guareguare, Miranda. UCV, Caracas, Venezuela. 45 BALZ E, BOYER A, BURAUD M, 2007 Enquête TRAMIL à Marie-Galante. U. Bordeaux 3, U. Paris XI Chatenay-Malabry, UAG, Guadeloupe. 46 BOYER A, BURAUD M, 2007 Enquête TRAMIL à La Désirade. U. Paris XI Chatenay-Malabry, UAG, Guadeloupe. 47 OCRISSE G, 2008 Enquête TRAMIL auprès de 250 familles de la moitié Est de la partie francophone de St Martin. Biologie végétale, UAG, Guadeloupe. 48 BOULOGNE I, 2009 Enquête TRAMIL, (Terre-de-Bas et Terre-de-Haut) Les Saintes, UAG, Guadeloupe. |
||
Eryngium foetidum(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf, decoction or infusion, orally3 |
Recommandations
Preparation and posology References |
According to published and other information: Use for fever is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies, scientific validation and available published scientific information. Use for flatulence, flue, vomiting, chest pain and attacks, palpitations and tiredness is classified as REC, based on the significant traditional use (OMS/WHO)4 documented in the TRAMIL surveys. Should there be a notable worsening of the patient’s condition, or should fever or vomiting last more than 2 days, seek medical attention. Not for use during pregnancy, during lactation or by children under 3 years old. |
The leaf ofEryngium foetidum is widely used for human consumption. For fever, flatulence, flu and vomiting: Prepare a decoction or infusion with 20-30 grams (2-3 spoonfuls) of leaf in 1L (4 cups) of water. For decoction, boil for at least 10 minutes in a covered pot. For infusion, add boiling water to 20-30 grams (2-3 spoonfuls) of leaf, cover and leave to cool down. Filter and drink 1 cup (250 mL) 3 times a day. For chest pain and attacks, palpitations and tiredness: There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. |
1 OCAMPO R, 1988 Encuesta TRAMIL (Costa atlántica), Instituto de Desarrollo Agrario, Universidad de Costa Rica, San José, Costa Rica. 2 CHARLES C, 1988 TRAMIL survey. Movement for Cultural Awareness MCA, Roseau, Dominica. 3 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 4LAGOS-WITTE S, 1988-1995 Encuestas TRAMIL. Laboratorio de Histología Vegetal y Etnobotánica, Departamento de Biología, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 5 WENIGER B, 1987-88 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 6 WHO, 1991 Pautas para la evaluación de medicamentos herbarios WHO/TRM/91.4 (original inglés). Programa de Medicina Tradicional, OMS, Ginebra, Suiza. 7 FORGACS P, JACQUEMIN H, MORETTI C, PROVOST J, TOUCHE A, 1983 Etude phytochimique et activités biologiques de 18 plantes de la Guyane Française. Plantes Médicinales Phytothér 17(1):22-32. 8 WONG K, FENG M, SAM T, TAN G, 1994 Composition of the leaf and root oils of Eryngium foetidum L. J Essent Oil Res 6(4):369-374. 9 MUNSELL H, Williams LO, Guild LP, Troescher CB, Nightingale G, Harris RS, 1950 Composition of food plants of Central America. IV: El Salvador. Food Res15(4):263-296. 10 ARBAIN D, CANNON JR, AFRIASTINI, KARTAWINATA K, DJAMAL R, BUSTARI A, DHARMA A, ROSMAWATY RIVAI H, ZAHERMAN, BASIR D, SJAFAR M, SJAIFUL, NAWFA R, KOSELA S, 1989 Survey of some West Sumatran plants for alkaloids. Econ Bot43(1):73-78. 11 HERRERA J, 1992 Determinación de parámetros farmacológicos usados en medicina tradicional popular en la Cuenca del Caribe. Departamento de Farmacología, Facultad de Salud, Universidad del Valle, Cali, Colombia. 12 SARAVIA A, 1992 Estudios sobre plantas TRAMIL. Departamento de Farmacología, Universidad de San Carlos, Guatemala, Guatemala. 13 GARCIA D, SAENZ T, 1995 Toxicidad aguda de algunas plantas TRAMIL. Informe TRAMIL. Farmacognosia, Facultad de Farmacia, Universidad de Sevilla, Sevilla, España. 14 SIMON O, SINGH N, 1986 Demonstration of anticonvulsant properties of an aqueous extract of spirit weed (Eryngium foetidum). Wi Med J 35(2):121-125. 15 SAUVAIN M, 1989 Etude des plantes antiparasitaires du plancton des Guyanes en Amazonie: antipaludiques et antileishmanioses (Thèse de Doctorat).Université Paris-Sud, Paris, France. 16 CACERES A, SAMAYOA B, 1989 Tamizaje de la actividad antibacteriana de plantas usadas en Guatemala para el tratamiento de afecciones gastrointestinales. Guatemala, Guatemala: Dirección General de Investigaciones, Universidad de San Carlos (DIGI-USAC). 17 GARCIA GM, COTO MT, GONZÁLEZ CS, PAZOS L, 1996 Toxicidad sub-crónica, en ratones, del extracto acuoso de la planta entera de Eryngium foetidum. Informe TRAMIL. Laboratorio de Ensayos Biológicos LEBI, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 18 PAZOS L, COTO T, GONZALEZ S, QUIROS S, 2004 Toxicidad oral, subcrónica en ratones, dosis repetidas, del extracto acuoso de planta entera de Eryngium foetidum. Informe TRAMIL. Laboratorio de Ensayos Biológicos, Universidad de Costa Rica, San Pedro, Costa Rica. 19 DELAIGUE J, 2005 TRAMIL survey. PRDI, Tobago House of Assembly, Scarborough, Tobago. 20 LONGUEFOSSE JL, NOSSIN E, 1990-95 Enquête TRAMIL. Association pour la valorisation des plantes médicinales de la Caraïbe AVPMC, Fort de France, Martinique. |
||
Foeniculum vulgare(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys seed and/or leaf, decoction, orally2 |
Recommandations
Preparation and posology References |
According to published and other information: Use for stomach pain, abdominal pain and flatulence is classified as REC, based on the significant traditional use documented in the TRAMIL surveys and available published scientific information. Should there be a notable worsening of the patient’s condition, or should stomach pain persist for more than 3 days, seek medical attention. Use for earache is classified as REC, based on the significant traditional use documented in the TRAMIL surveys and toxicity studies. Due to the potential health risks associated with earache, and to determine whether it is caused by middle and/or inner ear infection, an initial medical evaluation is recommended. Its use is contraindicated if symptoms such as ear secretions and/or evidence of perforation of the tympanic membrane are present. Before any application in the ear, strict hygienic measures should be observed in order to avoid contamination or further infection. Should there be a notable worsening of the patient’s condition, or should earache last more than 2 days, seek medical attention. Not for use during pregnancy, during lactation or by children under 3 years old. The seed can cause hypersensitivity and allergic reactions. |
The leaf of Foeniculum vulgare is widely used for human consumption and the seed is an industrial source of essential oil. For stomach pain, abdominal pain and flatulence: Prepare a decoction with 0.3-0.6 grams of dried seed or 3-5 grams of fresh leaves in 250 mL (1 cup) of water, boil for 10 minutes minimum in a covered pot, filter, allow to cool, and drink 1 cup 3 times a day24-25. For earache: There is no available information for establishing a means of preparation and dosage other than that referred to by traditional use. |
1 WENIGER B, ROUZIER M, 1986 Enquête TRAMIL. Service Oecuménique d'Entraide SOE, Port au Prince, Haïti. 2 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 3 HAGINIWA J, HARADA M, MORISHITA I, 1963 Pharmacological studies on crude drugs. VII. Properties of essential oil components of aromatics & their pharmacological effect on mouse intestine. Yakugaku Zasshi 83:624. 4 AKUNZEMANN J, HERRMANN K, 1977 Isolation and identification of flavon(ol)-O-glycosides in caraway (Carum carvi L.), fennel (Foeniculum vulgare Mill.), anise (Pimpinella anisum L.), and coriander (Coriandrum sativum L.), and of flavone-C-glycosides in anise. I. Phenolics of spices. Z Lebensm Unters Forsch 164:194-200. 5 HARANATH P, AKTHER M, SHARIF S, 1987 Acetylcholine and choline in common spices. Phytother Res 1(2):91-92. 6 ZOBEL A, BROWN S, 1991 Psoralens on the surface of seeds of Rutaceae and fruits of Umbelliferae and Leguminosae. Can J Bot 69(3):485-488. 7 CESKA O, CHAUDHARY S, WARRINGTON P, ASHWOOD-SMITH M, 1987 Photoactive furocoumarins in fruits of some Umbellifers. Phytochemistry 26(1):165-169. 8 MENDEZ J, CASTRO-POCEIRO J, 1981 Coumarins in Foeniculum vulgare fruits. Rev Latinoamer Quim 12:91-92. 9 SALEH N, EL-NEGOUMY S, EL-HADIDI M, HOSNI H, 1983 Comparative study of the flavonoids of some local members of the Umbelliferae. Phytochemistry22(6):1417-1420. 10 LATTANZIO V, MARCHESINI A, 1981 Determination of plant phenols by gel filtration. J Food Sci 46:1907-1909. 11 HARBONE J, BOARDLEY M, 1984 Use of high-performance liquid chromatography in the separation of flavonol glycosides and flavonol sulphates. J Chromatogr 299(2):377-385. 12 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants. Boca Raton, USA: CRC Press. p75. 13 CARBALLO A, 1995 Plantas medicinales del Escambray cubano. Informe TRAMIL. Laboratorio provincial de producción de medicamentos, Sancti Spiritus, Cuba. 14 LEIFERTOVA I, LISA M, 1986 The antifungal properties of higher plants affecting some species of the genus Aspergillus. Folia Pharm (Prague) 2:29-54. 15 MALINI T, VANITHAKUMARI G, MEGALA N, ANUSYA S, DEVI K, ELANGO V, 1985 Effect of Foeniculum vulgare Mill. seed extract on the genital organs of male and female rats. Indian J Physiol Pharmacol 29(1):21-26. 16 MASCOLO N, AUTORE G, CAPASSO F, MENGHINI A, FASULO MP, 1987 Biological screening of Italian medicinal plants for anti-inflammatory activity. Phytother Res 1(1):28-31. 17 DUKE JA, 1988 Handbook of medicinal herbs. Boca Raton, USA: CRC Press. 18 PINKAS M, BEZANGER-BEAUQUESNE L, 1986 Les plantes dans la thérapeutique moderne. Paris, France: 2 éd. Ed. Maloine. 19 ALBERT PULEO M, 1980 Fennel and anise as estrogenic agents. J Ethnopharmacol 2(4):337-344. 20 HURTADO M, CARBALLO A, 1990 Las plantas medicinales TRAMIL en la farmacopea soviética. Centro de Investigaciones de Fitoterapia y Medicina Tradicional, Topes de Collantes, Cuba. 21 ALFONSO H, 1992 Evaluación de la toxicidad dérmica deMomordica charantia L., Foeniculum vulgare Mill yCassia occidentalis L. en cobayos. Informe tramil. Centro Nacional de Salud Animal CENSA, La Habana, Cuba. 22 SHAH A, QURESHI S, AGEEL A, 1991 Toxicity studies in mice of ethanol extracts ofFoeniculum vulgare fruit andRuta chalepensis aerial parts. J Ethnopharmacol 34(2/3):167-172. 23 SEETHARAM K, PASRICHA J, 1987 Condiments and contact dermatitis of the finger-tips. Indian J Dermatol Venereol Leprol 53(6):325-328. 24 ASSOCIATION SCIENTIFIC COMMITTEE, 1983 British herbal pharmacopœia. Bournemouth, England: British Herbal Medicine Association. 25 CARBALLO A, 1995 Cálculo de concentración y dosis de las drogas vegetales TRAMIL: Mensuraciones farmacognósticas y aproximaciones técnico-clínicas. Laboratorio provincial de producción de medicamentos, Sancti Spiritus, Cuba. 26 MARTINEZ MJ, MOREJON Z, LOPEZ M, BOUCOURT E, FUENTES V, MORON F, 2005 Clases tóxicas agudas (CTA) de una decocción de hoja fresca de Foeniculum vulgare Miller.Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 27 MARTINEZ MJ, LOPEZ M, MOREJON Z, BOUCOURT E, FUENTES V, MORON F, 2005 Irritabilidad dérmica primaria del zumo filtrado de hojas frescas machacadas de Foeniculum vulgare Mill.Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. |
||
Mentha sp.(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf, decoction or infusion, orally3-4,37 |
Recommandations
Preparation and posology References |
According to published and other information: Use for diarrhea, stomach pain, flatulence, indigestion, flu, common cold and vomiting is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, and on available published scientific information. Should there be a notable worsening of the patient’s condition, or should the diarrhea or stomach pain last more than 3 days in adults or 2 days in children older than 3, or should vomiting persist for more than 2 days, seek medical attention. For diarrhea, the use of this resource can be considered complementary to oral re-hydration therapy. Do not ingest in case of adverse gall bladder conditions or stones7. Not for use during pregnancy, during lactation or by children under 5 years old. |
The leaf of Mentha spicata is widely used for human consumption andMentha piperita is an industrial source of essential oil. For stomach ache: Prepare an infusion adding 250 mL (1 cup) of boiling water to 1.5-3 grams (1 spoonful of dried leaf. Cover pot, let it settle for 5-10 minutes, and filter. For diarrhea, flatulence, indigestion, flu, common cold and vomiting: Prepare a decoction or infusion with 1.5-3 grams (1 spoonful) of dried leaf in 250 mL (1 cup) of water. In the case of a decoction, boil for at least 10 minutes in a covered pot; for infusion, add boiling water to 3 grams of dried leaf, cover, leave to cool down for 5-10 minutes, and filter. In all cases, drink 2-4 cups a day when required by symptomatic indication32-33. |
1 DELENS M, 1990-92 Encuesta TRAMIL. Centro al Servicio de la Acción Popular CESAP, Caracas, Venezuela. 2 CARBALLO A, 1990 Encuesta TRAMIL. Centro de investigación de fitoterapia y medicina tradicional de Topes de Collantes, Trinidad, Cuba. 3 CHARLES C, 1988 TRAMIL survey. Movement for Cultural Awareness MCA, Roseau, Dominica. 4 EDOUARD JA, 1992 Enquête TRAMIL. Lycée agricole, Baie-Mahault, Guadeloupe. 5 LONGUEFOSSE JL, NOSSIN E, 1990-95 Enquête TRAMIL. Association pour la valorisation des plantes médicinales de la Caraïbe AVPMC, Fort de France, Martinique. 6 SOLIS P, CORREA M, GUPTA M, 1995 Encuesta TRAMIL (Comunidades afro-caribeñas). Centro de Investigaciones Farmacognósticas de la Flora Panameña CIFLORPAN, Facultad de Farmacia, Universidad de Panamá, Panamá, Panamá. 7 CANIGUERAL S, VILA R, RISCO E, PEREZ F, PORTILLO A, FREIXA B, MILO B, VANACLOCHA B, RIOS JL, MORALES MA, ALONSO JR, BACHILLER LI, PERIS JB, STUBING G, 2002 Mentha sp. Vademecum de Fitoterapia, Editorial Masson, Barcelona, España, Nov. 20, 2003. URL: http://www.masson.es/book/fitoterapia.html 8 TAYLOR BA, DUTHIE HL, LUSCOMBE DK, 1985 Mechanism by which peppermint oil exerts its relaxant effect on gastrointestinal smooth muscle. J Pharm Pharmacol 37(Suppl):104. 9 GUEDON DJ, PASQUIER BP, 1994 Analysis and distribution of flavonoid glycosides and rosmarinic acid in 40 Mentha xpiperita clones. J Agr Food Chem 42(3):679-684. 10 HERRMANN EC, KUCERA LS, 1967 Antiviral substances in plants of the mint family (Labiatae). 3. Peppermint (Mentha piperita) and other mint plants. Proc Soc Exp Biol Med 124(3):874-878. 11 KIUCHI F, NAKAMURA N, MIYASHITA N, NISHIZAWA S, TSUDA Y, KONDO K, 1989 Nematocidal activity of some anthelmintic traditional medicines and spices by a new assay method using larvae of Toxocara canis. Shoyakugaku Zasshi 43(4):279-287. 12 LESLIE GB, 1978 A pharmacometric evaluation of nine bio-strath herbal remedies. Medita 8(10):3-19. 13 DELLA LOGGIA R, TUBARO A, LUNDER TL, 1990 Evaluation of some pharmacological activities of a peppermint extract. Fitoterapia 61(3):215-221. 14 DELLA LOGGIA R, TUBARO A, REDAELLI C, 1981 Valutazione dell'attività sul S.N.C. del topo di alcuni estratti vegetali e di una loro associazione. (Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them). Rivista di Neurologia 51(5):297-310. 15 COSTA M, DI STASI LC, KIRIZAWA M, MENDACOLLI SL, GOMES C, TROLIN G, 1989 Screening in mice of some medicinal plants used for analgesic purposes in the state of Sao Paulo. Part II. J Ethnopharmacol 27(1-2):25-33. 16 ROSS S, EL-KELTAWI N, MEGALLA S, 1980 Antimicrobial activity of some Egyptian aromatic plants. Fitoterapia 51:201-205. 17 SCORTICHINI M, ROSSI M, 1989 In vitro activity of some essential oils toward Erwinia amylovora (Burril) Winslow. Acta Phytopathol Entomol Hung 24(3/4):421-431. 18 RAI MK, UPADHYAY S, 1988 Laboratory evaluation of essential oil of Mentha piperita Linn. against Trichophyton mentagrophytes. Hindustan Antibiot Bull 30(3-4):82-84. 19 HARRIES N, JAMES KC, PUGH WK, 1978 Antifoaming and carminative actions of volatile oils. J Clin Pharmacol 2:171-177. 20 TADDEI I, GIACHETTI D, TADDEI E, MANTOVANI P, BIANCHI E, 1988 Spasmolytic activity of peppermint, sage and rosemary essences and their major constituents. Fitoterapia 59(6):463-468. 21 MELZIG M, TEUSCHER E, 1991 Investigations of the influence of essential oils and their main components on the adenosine uptake by cultivated endothelial cells. Planta Med 57(1):41-42. 22 LAM L, ZHENG B, 1991 Effects of essential oils on glutathione S-transferase activity in mice. J Agr Food Chem 39(4):660-662. 23 BRIGGS C, 1993 Peppermint: medicinal herb and flavouring agent. Can Pharmaceutical J 126(2):89-92. 24 DALVI SS, NADKARNI PM, PARDESI R, GUPTA KC, 1991 Effect of peppermint oil on gastric emptying in man: A preliminary study using a radiolabelled solid test meal. Indian J Physiol Pharmacol 35(3):212-214. 25 MAY B, KUNTZ HD, KIESER M, KOHLER S, 1996 Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneimittel Forschung [Drug Research] 46(12):1149-1153. 26 BEZIAT M, 1983 Toxicité d'huiles essentielles. Thèse Pharmacie, Montpellier, France. 27 CODE OF FEDERAL REGULATIONS, 2002 Food and drugs. Chapter I - Food and Drug administration, Department of Health and Human Services. Part 182 - Substances generally recognized as safe. Sec. 182.10. Spices and other natural seasonings and flavorings. U.S. Government Printing Office via GPO Access, USA. 21(3):451-452. Feb. 24, 2003, URL: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CF... 28 VIZOSO A, RAMOS A, VILLAESCUSA A, DECALO M, BETANCOURT J, 1997 Estudio genotóxico in vitro e in vivo en tinturas de Melissa officinalis L. (toronjil) y Mentha piperita L. (toronjil de menta). Rev Cub Plantas Med 2(1):6-11. 29 MICROMEDEX T, 2003 Healthcare Series. Vol. 117. 9/2003 Thomson MICROMEDEX®. 30 BUDAVARI S (Ed.), 2001 The Merck index: an encyclopedia of chemical, drugs, and biologicals. 30th ed. New Jersey, USA: Merck and Co., Inc. p1043-1044. 31 SIVASWAMY SM, BALACHANDRAN B, BALANEHRU S, SIVARAMAKRISHNAN VM, 1991 Mutagenic activity of south Indian food items. Indian J Exp Biol 29(8):730-737. 32 WICHTL M, 1999 Plantes thérapeutiques. Tec and Doc. p365. 33 ALONSO J, 1998 Tratado de fitomedicina: bases clínicas y farmacológicas. Buenos Aires, Argentina: ISIS ediciones SRL. p721. 34 MARTINEZ MJ, MOREJON Z, LOPEZ M, BOUCOURT E, FUENTES V, MORON F, 2005 Clases tóxicas agudas (CTA) de una decocción de hoja fresca de Mentha nemorosa Willd.Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 35 GUERRA MJ, LOPEZ M, BOUCOURT E, FUENTES V, MORON F, 2002 Clases tóxicas agudas en rata de decocción (30%) de hojas secas de Mentha x piperita varcitrata (Ehrh.) Briq.Informe TRAMIL. Laboratorio Central de Farmacología. Facultad de Medicina Dr. Salvador Allende. Ciudad de La Habana, Cuba. 36 GUERRA MJ, LOPEZ M, BOUCOURT E, FUENTES V, 2002 Toxicidad aguda (DL50) en ratón de la decocción de hojas secas de Mentha x piperita var citrata(Ehrh.) Briq.Informe TRAMIL. Laboratorio Central de Farmacología. Facultad de Medicina Dr. Salvador Allende. Ciudad de La Habana, Cuba. 37 BALZ E, BOYER A, BURAUD M, 2007 Enquête TRAMIL à Marie-Galante. U. Bordeaux 3, U. Paris XI Chatenay-Malabry, UAG, Guadeloupe. 38 OCRISSE G, 2008 Enquête TRAMIL auprès de 250 familles de la moitié Est de la partie francophone de St Martin. Biologie végétale, UAG, Guadeloupe. |
||
Ocimum gratissimum(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf, decoction or infusion, orally2-3 |
Recommandations
Preparation and posology References |
According to published and other information: Use for abdominal pain and flatulence, asthenia and weakness is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, and on available published scientific information. Should there be a notable worsening of the patient’s condition, or should abdominal pain last more than 3 days, seek medical attention. Use for torsalo (myiasis) is classified as REC, based on the significant traditional use (OMS/WHO)4 documented in the TRAMIL surveys. For topical application, strict hygiene measures should be observed in order to avoid contamination or additional infection. Not for use during pregnancy, during lactation or by children under 5 years old. |
The leaves of Ocimum gratissimum are widely used for human consumption. For abdominal pain and flatulence: Prepare a decoction or infusion with 5-7 grams (1-2 spoonfuls) of leaves in 1/2 liter (2 cups) of water. In case of decoction, boil for at least 10 minutes in a covered pot (possibly, with a pinch of salt). For infusion, add boiling water to the leaves, cover and leave to cool. Filter and drink 1 cup 3 times per day. For abdominal pain, there is no available information establishing a means of preparation and dosage regarding the leaf juice other than that referred to by traditional use. For torsalo (myiasis): There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. Any medicinal preparation must be preserved cold and used within the 24 hours. |
1 WENIGER B, 1987-88 2 WENIGER B, ROUZIER M, 1986 3 JEAN-PIERRE L, 1988 4 GIRÓN L, 1988 5 WHO, 1991 6 WENIGER B, SAVARY H, DAGUIHL R, 1984 7 ZAMUREENKO VA, TOKAREVA VY, KLYUEV NA, KARPOVA TI, GRANDBERG TI, 1981 8 NTEZURUBANZA L, SCHEFFER JJC, BAERHEIM-SVENDSEN A, 1987 9 ARCTANDER S, 1960 10 HEGNAUER R, 1973 11 MAIA JGS, RAMOS LS, LUZ AIR, DA SILVA ML, ZOGHBI MG, 1988 12 JANSSEN AM, SCHEFFER JJC, NTEZURUBANZA L, SVENDSEN AB, 1989 13 NIGAM M, KHOSLA MK, BRADU BL, TANDON N, 1988 14 AWUAH RT, 1989 15 OFFIAH VN, CHIKWENDU UA, 1999 16 AZIBA PI, BASS D, ELEGBE Y, 1999 17 NJOKU CJ, ASUZU IU, 1998 18 ADESINA SK, 1982 19 EL KELTAWI N, MEGALLA S, ROSS S, 1980 20 MADEIRA SVF, MATOS FJ, LEAL-CARDOSO JH, CRIDDLE DN, 2002 21 BUDAVARI S (Ed.), 2001 22 ONAJOBI FD, 1986 23 LOGARTO PARRA A, TILLAN CAPO J, VEGA MONTALVO R, GONZALEZ YC, 1999 24 DHAWAN BN, PATNAIK GK, RASTOGI RP, SINGH KK, TANDON JS, 1977 25 LOGARTO PARRA A, SILVA YHEBRA R, GUERRA SARDINAS I, IGLESIAS BUELA L, 2001 26 GUERRA MJ, LÓPEZ M, BOUCOURT E, FUENTES V, MORÓN F, 2002 27 GUERRA MJ, LÓPEZ M, BOUCOURT E, FUENTES V, MORÓN F, 2002 28 GUERRA MJ, LÓPEZ M, BOUCOURT E, FUENTES V, 2002 29 GUERRA MJ, LÓPEZ M, BOUCOURT E, FUENTES V, 2002 |
||
Persea americana(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf, decoction, orally3 |
Recommandations
Preparation and posology References |
According to published and other information: Use for amenorrhea is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies, scientific validation and available published scientific information. Use for asthma, bronchitis, flatulence, urinary infection and cough is classified as REC, based on the significant traditional use documented in the TRAMIL surveys and toxicity studies. Should there be a notable worsening of the patient’s condition, or should asthma, bronchitis or cough last more than 5 days, or should urinary infection persist for more than 3 days, seek medical attention. Due to the risks of documented interactions with warfarin and monoamine-oxidase inhibitors (MAOI), ingestion of the fruit decoction should be avoided by persons taking these medicines5. Not for use during lactation or by children under 3 years old.
Not for use during pregnancy because it may have abortifacient effect. |
The fruit of Persea americana is widely used for human consumption. For amenorrhea, asthma, bronchitis, flatulence, urinary infection and cough: Prepare a decoction with 20 grams (3 spoonfuls) of ground leaf in 1 liter (4 cups) of water, boil for at least 10 minutes in a covered pot. Filter, allow to cool and drink 1/2-1 cup 3-4 times a day26. Any medicinal preparation must be preserved cold and used within the 24 hours. |
1 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 2 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala, Guatemala. 3 LONGUEFOSSE JL, NOSSIN E, 1990-95 Enquête TRAMIL. Association pour la valorisation des plantes médicinales de la Caraïbe AVPMC, Fort de France, Martinique. 4 MENDEZ M, MEDINA ML, DURAN R, 1996 Encuesta TRAMIL. Unidad de recursos naturales, Centro de Investigación Científica de Yucatán CICY, Mérida, México. 5 CANIGUERAL S, VILA R, RISCO E, PEREZ F, PORTILLO A, FREIXA B, MILO B, VANACLOCHA B, RIOS JL, MORALES MA, ALONSO JR, BACHILLER LI, PERIS JB, STUBING G, 2002 Persea americana. Vademecum de Fitoterapia, Editorial Masson, Barcelona, España, Feb. 26, 2003. URL: http://www.masson.es/book/fitoterapia.html 6 BERGH BO, SCORA RW, STOREY WB, 1973 Comparison of leaf terpenes in Persea subgenus persea. Bot Gaz (Chicago) 134:130-134. 7 KING JR, KNIGHT RJ, 1992 Volatile components of the leaves of various avocado cultivars. J Agric Food Chem 40(7):1182-1185. 8 DE ALMEIDA AP, MIRANDA MMFS, SIMONI IC, WIGG MD, LAGROTA MHC, COSTA SS, 1998 Flavonol monoglycosides isolated from the antiviral fractions of Persea americana (Lauraceae) leaf infusion. Phytother Res 12(8):562-567. 9 MERIÇLI F, MERIÇLI AH, YILMAZ F, YÜNCÜLER G, YÜNCÜLER O, 1992 Flavonoids of avocado (Persea americana) leaves. Acta Pharm Turc 34(2):61-63. 10 BATE-SMITH EC, 1975 Phytochemistry of proanthocyanidins. Phytochemistry 14(4):1107-1113. 11 MURAKOSHI S, ISOGAI A, CHANG CF, KAMIKADO T, SAKURAI A, TAMURA S, 1976 The effects of two components from avocado leaves (Persea americana) and related compounds on the growth of silkworm larvae, Bombyx mori. Nippon Oyo Dobutsu Konchu Gakkaishi 20:87-91. 12 HIRAI N, KOSHIMIZU K, 1983 A new conjugate of dihydrophaseic acid from avocado fruit. Agr Biol Chem 47(2):365-371. 13 WILSON C, WILSON III CW, SAW PE, NAGY S, 1979 Analysis of monosaccharides in avocado by HPLC. Liq Chromat Anal Food Beverages 1:225-236. 14 SARDI JC, TORRES OA, 1978 Study on avocado (Persea americana) oil. Arch Bioquim Quim Farm 20:45-49. 15 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants. Boca Raton, USA: CRC Press. p324. 16 CACERES A, GONZALEZ S, GIRON L, 1998 Demostración de la actividad antimicrobiana de plantas TRAMIL en base a los usos populares en la cuenca del Caribe. Informe TRAMIL. Laboratorio de productos fitofarmacéuticos Farmaya y Facultad de ciencias químicas y farmacia, Universidad de San Carlos, Guatemala, Guatemala. 17 HERRERA J, 1986 Determinación de actividades biológicas de vegetales utilizados en medicina tradicional. Informe TRAMIL. Dep. de Farmacología, Facultad de Salud, Universidad del Valle, Cali, Colombia. 18 GarcIa GM, Coto MT, GonzAlez CS, Pazos L, 1999 Actividad bronquial del extracto acuoso de hoja fresca de Persea americana. Informe TRAMIL. Laboratorio de Ensayos Biológicos LEBI, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 19 PAZOS L, COTO T, GONZALEZ S, QUIROS S, 2003 Tránsito intestinal, en ratones, del extracto acuoso de hojas frescas de Persea americana. Informe TRAMIL. Laboratorio de Ensayos Biológicos, Universidad de Costa Rica, San Pedro, Costa Rica. 20 ADEYEMI OO, OKPO SO, OGUNTI OO, 2002 Analgesic and anti-inflammatory effects of the aqueous extract of leaves of Persea americana Mill Lauraceae. Fitoterapia 73(5):375-380. 21 MIWA M, KONG ZL, SHINOHARA K, WATANABE M, 1990 Macrophage stimulating activity of foods. Agric Biol Chem 54(7):1863-1866. 22 HERRERA J, 1988 Determinación de actividades biológicas de vegetales utilizados en medicina tradicional. Informe TRAMIL. Laboratorio de fitofarmacología, Dep. de Farmacología, Facultad de Salud, Universidad del Valle, Cali, Colombia. 23 GarcIa GM, Coto MT, GonzAlez CS, Pazos L, 2000 Toxicidad aguda en ratones, del extracto acuoso de hojas frescas de Persea americana. Informe TRAMIL. Laboratorio de Ensayos Biológicos LEBI, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 24 CRAIGMILL AL, SEAWRIGHT AA, MATTILA T, FROST AJ, 1989 Pathological changes in the mammary gland and biochemical changes in milk of the goat following oral dosing with leaf of the avocado (Persea americana). Aust Vet J 66(7):206-211. 25 GRANT R, BASSON PA, BOOKER HH, HOFHERR JB, ANTHONISSEN M, 1991 Cardiomyopathy caused by avocado (Persea americana Mill.) leaves. J S Afr Vet Assoc 62(1):21-22. 26 ALONSO J, 1998 Tratado de fitomedicina. Bases clínicas y farmacológicas. Buenos Aires, Argentina: ISIS ediciones SRL. p185. 27 LOPEZ M, MARTINEZ MJ, MOREJON Z, BOUCOURT E, FUENTES V, MORON F. 2005 Irritabilidad dérmica primaria de hoja fresca machacada de Persea americana Mill. Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Medicina “Dr. Salvador Allende”, Cerro, C. Habana, Cuba. 28 MORON FJ, GARCIA AI, VICTORIA MC, MOREJON Z, LOPEZ M, BACALLAO Y, FUENTES V, 2008 Acción analgésica de la decocción de hojas frescas de Persea americana Mill. (aguacate) en ratones. Trabajo TRAMIL. Laboratorio Central de Farmacología. Universidad de Ciencias Médicas de La Habana. |
||
Petiveria alliacea(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys root, infusion, orally5 |
Recommandations
Preparation and posology References |
According to published and other information: Use for digestive conditions (stomach pain, bad or slow digestion and intestinal gas) toothache, muscle pain, skin diseases, rheumatism and common cold is classified as REC, based on the significant traditional use documented in the TRAMIL surveys and toxicity studies. Should there be a notable worsening of the patient’s condition, or should stomach pain persist for more than 3 days, seek medical attention. Use for headache, flatulence, flu and nasal congestion (sinusitis) is classified as REC, based on the significant traditional use (OMS/WHO)11 documented in the TRAMIL surveys. For topical application, strict hygiene measures should be observed in order to avoid contamination or additional infection. Considering the risks of documented interactions with insulin or oral hypoglycemiants, the decoction of the leaf and stem should not be ingested by patients taking or using these medicines due to the risk of magnifying their effects. The root and the stem can cause reactions of hypersensitivity. Not for use during lactation or by children under 12 years old. Not for use during pregnancy because it may be abortifacient. |
For digestive conditions and common cold: Prepare a decoction with 30 grams (3 spoonfuls) of ground leaf in 1 liter of water (4 cups). Boil for at least 10 minutes in a covered pot. Filter, allow to cool and drink 2-3 cups a day37. For rheumatism: Prepare a decoction with 30 grams (3 spoonfuls) of ground leaf and root in 1 liter of water (4 cups) for at least 10 minutes in a covered pot. Filter, leave to cool down and drink 2-3 cups a day37. For nasal congestion (sinusitis): Prepare a fine powder of the root and stem from dried and sieved material, inhale 0.2 to 0.5 grams through each nostril, 2 times a day38. For headache, toothache, muscle pain, flatulence, flu and skin diseases: There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. Any medicinal preparation must be preserved cold and used within the 24 hours. |
1 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala, Guatemala. 2 WENIGER B, ROUZIER M, 1986 Enquête TRAMIL. Service Oecuménique d'Entraide SOE, Port au Prince, Haïti. 3 WENIGER B, 1987-88 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 4 Castillo D, Rodriguez S, de los Santos C, Belen A, 2003 Encuesta TRAMIL (región Este). Dep. de Botánica, Jardín Botánico Nacional, Santo Domingo, Rep. Dominicana. 5 CHARLES C, 1988 TRAMIL survey. Movement for Cultural Awareness MCA, Roseau, Dominica. 6 LAGOS-WITTE S, Tinoco R, Merlo V, 1996 Encuesta complementaria TRAMIL. Laboratorio de Histología Vegetal y Etnobotánica, Dep. de Biología, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 7 GOMEZ H, GAITAN R, DIAZ F, 2003 Encuesta TRAMIL (Norte del departamento de Bolívar). Grupo de Productos Naturales, Facultad de Ciencias Químicas y Farmacéuticas. Universidad de Cartagena, Cartagena de Indias, Colombia. 8 SOLIS P, CORREA M, GUPTA M, 1995 Encuesta TRAMIL (Comunidades afro-caribeñas). Centro de Investigaciones Farmacognósticas de la Flora Panameña CIFLORPAN, Facultad de Farmacia, Universidad de Panamá, Panamá, Panamá. 9 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 10 Castillo D, Rodriguez S, de los Santos C, Belen A, 2003 Encuesta TRAMIL (Zambrana, Cotuí). Dep. de Botánica, Jardin Botánico Nacional, Santo Domingo, Rep. Dominicana. 11 WHO, 1991 Pautas para la evaluación de medicamentos herbarios WHO/TRM/91.4 (original inglés). Programa de Medicina Tradicional, OMS, Ginebra, Suiza. 12 WENIGER B, SAVARY H, DAGUIHL R, 1984 Tri phytochimique de plantes de la liste TRAMIL. Laboratoire de chimie des substances naturelles, Faculté de Médecine et de Pharmacie, Université d'Etat d'Haïti, Port au Prince, Haïti. 13 HEGNAUER R, 1973 Chemotaxonomy der Pflanzen. Basel, Schweiz: Birkhauser Verlag. 6:882. 14 SEGELMAN F, SEGELMAN A, 1975 Constituents of Petiveria alliacea. Lloydia 38(6):537. 15 DE SOUSA JR, DEMUNER AJ, PINHEIRO JA, BREITMAIER E, CASSELS BK, 1990 Dibenzyl trisulphide and trans-N-methyl-4-methoxyproline fromPetiveria alliacea. Phytochemistry 29(11):3653-3655. 16 FURONES JA, MORON F, PINEDO Z, 1996 Ausencia de la acción analgésica de la Petiveria alliacea (anamu) en ratones. Rev Cubana Planta Med 1(1):16-18. 17 DEL CARMEN RIVAS C, JIMENEZ M, AYALA L, CARILLO C, CABRERA Y, 1988 Actividad anti-inflamatoria y analgésica dePetiveria alliaceae. Informe TRAMIL. Centro de Investigación y Desarrollo de Medicamentos (CIDEM), La Habana, Cuba. 18 FURONES JA, MORON F, PINEDO Z, 1996 Ausencia de actividad antiinflamatoria del extracto acuoso liofilizado de Petiveria alliacea (anamú) en ratas. Informe TRAMIL. Rev Cubana Planta Med 1(2):34-37. 19 Martinez MJ, Betancourt J, Lopez M, MorejOn Z, Fuentes V, MORON F, PINEDO Z, Boucourt E, 2001 Actividad antimicrobiana y sobre varias preparaciones de músculo liso, in vitro, de la decocción liofilizada de hoja de Petiveria alliacea.Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 20 GarcIa GM, Coto MT, GonzAlez CS, Pazos L, 1995 Velocidad del tránsito intestinal en ratones, del extracto acuoso de hoja fresca de Petiveria alliacea. Informe TRAMIL. Laboratorio de Ensayos Biológicos LEBI, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 21 ECHEVARRIA A, TORRES D, 2001 Efecto de un extracto de Petiveria alliacea Lin sobre el crecimiento de Giardia lamblia in vitro. Rev Cubana Med Mil 30(3):161-165. 22 CACERES A, GIRON LM, ALVARADO SR, TORRES MF, 1987 Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases. J Ethnopharm20(3):223-237. 23 CACERES A, LOPEZ BR, GIRON MA, LOGEMANN H, 1991 Plants used in Guatemala for the treatment of dermatophytic infections. 1. Screening for the antimicotic activity of 44 plant extracts. J Ethnopharm 31(3):263-276. 24 SAUVAIN M, 1989 Etude de plantes antiparasitaires du plateau des Guyanes en Amazonie: antipaludiques et antileishmaniens (Thèse de Doctorat). Université Paris-Sud, Paris, France. 25 RUFFA MJ, PERUSINA M, ALFONSO V, WAGNER ML, SURIANO M, VICENTE C, CAMPOS R, CAVALLARO L, 2002 Antiviral activity of Petiveria alliacea against the bovine viral diarrhea virus. Chemotherapy 48(3):144-147. 26 CACERES A, JAUREGUI E, HERRERA D, LOGEMANN H, 1991 Plants used in Guatemala for the treatment of dermatomucosal infections. 1: Screening of 38 plant extracts for anticandidal activity. J Ethnopharm 33(3):277-283. 27 LORES RI, PUJOL MC, 1990 Petiveria alliacea L. (anamu). Study of the hypoglycemic effect. Med Interne 28(4):347-352. 28 GERMANO DH, CALDEIRA TT, MAZELLA AA, SERTIE JA, BACCHI EM, 1993 Topical anti-inflammatory activity and toxicity of Petiveria alliacea. Fitoterapia 64(5):459-467. 29 FERRAZ MB, PEREIRA RB, IWATA NM, ATRA E, 1991 Tipi. A popular analgesic tea. A double blind cross-over trial in osteoarthritis. Clin Exp Rheumatol 9(2):205-206. 30 LIMA TCM, MORATO GS, TAKAHASHI RN, 1991 Evaluation of antinociceptive effect of Petiveria alliacea (guiné) in animals. Mem Inst Oswaldo Cruz 86(suppl.2):153-158. 31 GarcIa GM, Coto MT, GonzAlez CS, Pazos L, 1996 Toxicidad sub-crónica en ratones, del extracto acuoso de hojas frescas de Petiveria alliacea. Informe TRAMIL. Laboratorio de Ensayos Biológicos LEBI, Universidad de Costa Rica, San Pedro, Costa Rica. 32 GUERRA MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BOUCOURT E, FUENTES V, MORON F, 2001 Toxicidad aguda (DL50) oral de la decocción de hojas jóvenes frescas de Petiveria alliaceaL.Informe TRAMIL. Laboratorio Central de Farmacología. Facultad de Medicina Dr. Salvador Allende. Ciudad de La Habana, Cuba. 33 GUERRA MO, OLIVEIRA AB, MAIA JGS, PETERS VM, 1989 Alteraçäo do desenvolvimento embrionário de ratos após tratamento com extratos aquosos de diferentes orgäos de Petiveria alliacea. Bol Centro Biol Reprod 8:17-22. 34 GERMANO DHP, SERTIE JAA, BACCHI EM, 1995 Pharmacological assay of Petiveria alliacea. II. Oral anti-inflammatory activity and gastrotoxicity of a hydroalcoholic root extract. Fitoterapia 66(3):195-202. 35 REYNOLDS J Ed., 1996 Martindale: The extra pharmacopoeia. Evaluated information on the world’s drugs and medicines. 31st ed. London, England: The Royal Pharmaceutical Society. p1678. 36 BUDAVARI S Ed., 2001 The Merck Index: an encyclopedia of chemical, drugs, and biologicals. 30th ed. Whitehouse Station, USA: Merck & Co., Inc. p181. 37 ALBORNOZ A, 1993 Medicina tradicional herbaria. Caracas, Venezuela: Editorial Instituto Farmacoterápico Latino S.A. p298. 38 CARBALLO A, 1995 Cálculo de concentración y dosis de las drogas vegetales TRAMIL: Mensuraciones farmacognósticas y aproximaciones técnico-clínicas. Laboratorio provincial de producción de medicamentos, Sancti Spiritus, Cuba. 39 GUERRA MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BOUCOURT E, FUENTES V, 2001 Genotoxicidad in vivo: ensayo de morfología de la cabeza del espermatozoide en ratones de decocción liofilizada de hojas frescas de Petiveria alliacea L.Informe TRAMIL. Laboratorio Central de Farmacología. Facultad de Medicina Dr. Salvador Allende, Ciudad de La Habana, Cuba. 40 GUERRA MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BOUCOURT E, FUENTES V. 2001 Genotoxicidad in vivo: ensayo de micronúcleos en médula ósea de decocción liofilizada de hoja fresca de Petiveria alliacea L. Informe TRAMIL. Laboratorio Central de Farmacología. Facultad de Medicina Dr. Salvador Allende, Ciudad de La Habana, Cuba. 41 GUERRA MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BOUCOURT E, FUENTES V, 2001 Genotoxicidad in vitro: mediante el sistema de ensayo con Aspergillus nidulans de decocción liofilizada de hoja fresca Petiveria alliacea L. Informe TRAMIL. Laboratorio Central de Farmacología. Facultad de Medicina Dr. Salvador Allende, Ciudad de La Habana, Cuba. 42 GUERRA MJ, BETANCOURT J, LOPEZ M, MOREJON Z, BOUCOURT E, FUENTES V, 2001 Toxicidad aguda (DL50) intraperitoneal de la decocción liofilizada de hojas frescas de Petiveria alliaceaL.Informe TRAMIL. Laboratorio Central de Farmacología. Facultad de Medicina Dr. Salvador Allende. Ciudad de La Habana, Cuba. 43 CACERES A, LOPEZ B, GONZALEZ S, BERGER I, TADA I, MAKI J, 1998 Plants used in Guatemala for the treatment of protozoal infections. I. Screening of activity to bacteria, fungi and American trypanosomes of 13 native plants. J of Ethnopharmacology 62(3):195-202. |
||
Zingiber officinale(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys rhizome, decoction, orally9,11-12 |
Recommandations
Preparation and posology References |
According to published and other information: Uses for catarrh, flu, cold, fever, vomiting, diarrhea, stomach pain, flatulence and indigestion are classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies and available published scientific information. Uses for asthma, cough and whooping cough are classified as REC, based on the significant traditional use (OMS/WHO)13 documented in the TRAMIL surveys. Should there be a notable worsening of the patient’s condition, or should stomach pain, fever or vomiting persist for more than 2 days, seek medical attention. Due to the health risks involved with whooping cough, an initial medical evaluation is recommended. The use of this resource can be considered complementary to medical treatment. Not for use during lactation or by children under 6 years old14. Ginger may increase bioavailability of sulfaguanidine by maximizing its absorption. Patients who are receiving oral anticoagulants or anti-platelet aggregation treatments should seek the advice of their physician before taking any ginger preparations, due to increased risks of hemorrhage. It is recommended that patients with gallstones seek the advice of their physician before taking any ginger preparations15. |
The rhizome of Zingiber officinale is widely used for human consumption and is an industrial source of essential oil. According to ESCOP, ginger rhizome has been prescribed for the prevention of nausea and vomiting resulting from motion sickness (sea sickness) and as a post-surgical anti-emetic in minor surgeries. The effectiveness of both indications has been confirmed by clinical assays. The indications approved by Commission E are: dyspepsia and prevention of the gastrointestinal symptoms of motion sickness68. For asthma, catarrh, flu, cold, stomach pain, fever, indigestion, cough, whooping cough, vomiting and flatulence: Prepare a decoction with 5 grams of fresh rhizome in 250 mL (1 cup) of water. Boil for at least 10 minutes in a covered pot, leave to cool down and drink 2 to 4 times a day. Any medicinal preparation must be preserved cold and used within the 24 hours. |
1 DELENS M, 1990 Encuesta TRAMIL en Barlovento, Edo. Miranda de Venezuela. Centro al Servicio de la Acción Popular CESAP, Caracas, Venezuela. 2 BENEDETTI MD, 1994 Encuesta TRAMIL. Universidad de Puerto Rico, Mayagüez, Puerto Rico. 3 LAGOS-WITTE S, 1988-89, 1996 Encuesta TRAMIL. Laboratorio de Histología Vegetal y Etnobotánica, Departamento de Biología, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 4 DELENS M, 1992 Encuesta TRAMIL en los Estados Lara y Sucre de Venezuela. Centro al Servicio de la Acción Popular CESAP, Caracas, Venezuela. 5 OCAMPO R, 1988 Encuesta TRAMIL (Costa atlántica), Instituto de Desarrollo Agrario, Universidad de Costa Rica, San José, Costa Rica. 6 O'REILLY A, WILSON V, PHILLIP M, JOSEPH O, 1992 TRAMIL survey. Chemistry and Food Technology Division, Ministry of Agriculture, Dunbars, Antigua and Barbuda. 7 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 8 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala, Guatemala. 9 JEAN-PIERRE L, 1988 TRAMIL survey. St. Lucia national herbarium, Castries, St. Lucia. 10 CHARLES C, 1988 TRAMIL survey. Movement for Cultural Awareness MCA, Roseau, Dominica. 11 FAUJOUR A, MURREY D, CHELTENHAM-CORBIN B, CARRINGTON S, 2003 TRAMIL survey. enda-caribbean, IICA & UAG, Saint Thomas, Barbados. 12 BALLAND V, GLASGOW A, SPRINGER F, GAYMES G, 2004 TRAMIL survey. enda-caribbean, IICA, UAG & U.PARIS XI, Saint Vincent. 13 WHO, 1991 Pautas para la evaluación de medicamentos herbarios WHO/TRM/91.4 (original inglés). Programa de Medicina Tradicional, OMS, Ginebra, Suiza. 14 WHO, 1999 Rhizoma zingiberis. WHO monographs on selected medicinal plants, Volume I. WHO: Geneva, Switzerland. p284. 15 CANIGUERAL S, 2003 Zingiber officinalis. Vademecum de Fitoterapia, Editorial Masson, Barcelona, España, Jul. 30, 2003. URL: http://www.masson.es/book/fitoterapia.html 16 TANABE M, YASUDA M, ADACHI Y, KANOY, 1991 Capillary GC-MS analysis of volatile components in Japanese gingers. Shoyakugaku Zasshi 45(4):321-326. 17 NISHIMURA O, 1995 Identification of the characteristic odorants in fresh rhizomes of ginger (Zingiber oficinale Roscoe) using aroma extract dilution analysis and modified multidimensional gas chromatography-mass spectroscopy. J Agric Food Chem 43(11):2941-2945. 18 SAKAMURA F, OGIHARA K, SUGA T, TANIGUCHI K, TANAKA R, 1986 Volatile constituents of Zingiber officinale rhizomes produced by in vitro shoot tip culture. Phytochemistry 25(6):1333-1335. 19 WU P, KUO MC, HO CT, 1990 Glycosidically bound aroma compounds in ginger (Zingiber officinale Roscoe). J Agric Food Chem 38(7):1553-1555. 20 HAGINIWA J, HARADA M, MORISHITA I, 1963 Pharmacological studies on crude drugs. VII. Properties of essential oil components of aromatics and their pharmacological effect on mouse intestine. Yakugaku Zasshi 83:624. 21 VAN BEEK TA, LELYVELD GP, 1991 Isolation and identification of the five major sesquiterpene hydrocarbons of ginger. Phytochem Anal 2(1):26-34. 22 SHIBA M, MYATA A, OKADA M, WATANABE K, 1986 Antiulcer furanogermenone extraction from ginger. Patent-Japan Kokai Tokkyo Koho-61 227,523. 23 YOSHIKAWA M, HATAKEYAMA S, CHATANI N, NISHINO Y, YAMAHARA J, 1993 Qualitative and quantitative analysis of bioactive principles in Zingiberis Rhizoma by means of high performance liquid chromatography and gas liquid chromatography. On the evaluation of Zingiberis Rhizoma and chemical change of constituents during Zingiberis Rhizoma processing. Yakugaku Zasshi 113(4):307-315. 24 TANABE M, CHEN YD, SAITO KI, KANO Y, 1993 Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chem Pharm Bull 41(4):710-713. 25 KANO Y, TANABE M, YASUDA M, 1990 On the evaluation of the preparation of Chinese medicinal prescriptions (V) diterpenes from Japanese ginger "kintoki". Shoyakugaku Zasshi 44(1):55-57. 26 KAWAKISHI S, MORIMITSU Y, OSAWA T, 1994 Chemistry of ginger components and inhibitory factors of the arachidonic acid cascade. Asc Symp Ser 547:244-250. 27 KIKUZAKI H, NAKATANI N, 1993 Antioxidant effects of some ginger constituents. J Food Sci 58(6):1407-1410. 28 KIUCHI F, IWAKAMI S, SHIBUYA M, HANAOKA F, SANKAWA U, 1992 Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 40(2):387-391. 29 HARVEY DJ, 1981 Gas chromatographic and mass spectrometric studies of ginger constituents. identification of gingerdiones and new hexahydrocurcumin analogues. J Chromatogr 211(1):75-84. 30 MASADA Y, INOUE T, HASHIMOTO K, FUJIOKA M, UCHINO C, 1974 Studies on the constituents of ginger (Zingiber officinale Roscoe) by GC-MS. Yakugaku Zasshi 94(6):735-738. 31 ANON, 1982 Analgesic formulations containing shogaol and gingerol. Patent-Japan Kokai Tokkyo Koho-82 46,914. 32 CHEN CC, ROSEN RT, HO CT, 1986 Chromatographic analyses of isomeric shogaol compounds derived from isolated gingerol compounds of ginger (Zingiber officinale Roscoe). J Chromatogr 360:175-184. 33 HARTMAN M, 1971 Chemical composition of certain products from ginger (Zingiber officinale). Zivocisna Vyroba 16(10/11):805-812. 34 SCHULTZ JM, HERRMANN K, 1980 Occurrence of hydroxybenzoic acids and hydroxycinnamic acid in spices. IV. Phenolics of spices. Z Lebensm-Unters Forsch 171:193-199. 35 FU HY, HUANG TC, HO CT, DAUN H, 1993 Characterization of the major anthocyanin in acidified green ginger (Zingiber officinale Roscoe). Zhongguo Nongye Huaxue Huizhi 31(5):587-595. 36 NELSON EK, 1920 Constitution of capsaicin, the pungent principle of ginger. II. J Amer Chem Soc 42:597-599. 37 LIN ZK, HUA YF, 1987 Chemical constituents of the essential oil from Zingiber officinale Roscoe. of Sichuan. You-Ji Hua Hsueh 6:444-448. 38 ERLER J, VOSTROWSKY O, STROBEL H, KNOBLOCH K, 1988 Essential oils from ginger (Zingiber officinalis Roscoe). Z Lebensm-Unters Forsch 186(3):231-234. 39 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants.Boca Raton, USA: CRC Press. p172. 40 KIUCHI F, SHIBUYA M, KINOSHITA T, SANKAWA U, 1983 Inhibition of prostaglandin biosynthesis by the constituents of medicinal plants. Chem Pharm Bull 31(10):3391-3396. 41 KIUCHI F, SHIBUYA M, SANKAWA U, 1982 Inhibitors of prostaglandin biosynthesis from ginger. Chem Pharm Bull 30(2):754-757. 42 SANKAWA U, 1983 Modulators of arachidonate cascade contained in medicinal plants used in traditional medicine. 3º Congress of the Federation of Asian and Oceanian biochemists, Bangkok, Thailand, p28. 43 SRIVASTAVA KC, 1984 Aqueous extracts of onion, garlic and ginger inhibited platelet aggregation and altered arachidonic acid metabolism. Biomed Biochim Acta 43(8/9):5335-5346. 44 ADACHI I, YASUTA A, MATSUBARA T, UENO M, TERASAWA K, HORIKOSHI I, 1984 Macrophage procoagulant activity. Effects of hot water extracts of several Kanpo-prescriptions on macrophage procoagulant activity, I. Yakugaku Zasshi 104(9):959-965. 45 MASCOLO N, JAIN R, JAIN SC, CAPASSO F, 1989 Ethnopharmacologic investigation of ginger (Zingiber officinale). J Ethnopharmacol 27(1/2):129-140. 46 WOO W, LEE E, HAN B, 1979 Biological evaluation of Korean medicinal plants. III. Arch Pharm Res 2:127-131. 47 MAY G, WILLUHN G, 1978 Antiviral activity of aqueous extracts from medicinal plants in tissue cultures. Arzneim-Forsch 28(1):1-7. 48 ADEWUNMI CO, 1984 Natural products as agents of schistosomiasis control in Nigeria: A review of progress. Int J Crude Drug Res 22(4):161-166. 49 FEROZ H, KHARE AK, SRIVASTAVA MC, 1982 Review of scientific studies on anthelmintics from plants. J Sci Res Pl Med 3:6-12. 50 PANTHONG A, SIVAMOGSTHAM P, 1974 Pharmacological study of the action of ginger (Zingiber officinale Roscoe) on the gastrointestinal tract. Chien Mai Med Bull 13(1):41-53. 51 KASAHARA Y, SAITO E, HIKINO H, 1983 Pharmacological actions of Pinellia tubers and Zingiber rhizomes. Shoyakugaku Zasshi 37(1):73-83. 52 SAKAI K, MIYAZAKI Y, YAMANE T, SAITOH Y, IKAWA C, NISHIHATA T, 1989 Effect of extracts of Zingiberaceae herbs on gastric secretion in rabbits. Chem Pharm Bull 37(1):215-217. 53 YAMAHARA J, RONG HQ, NAITOH Y, KITANI T, FUJIMURA H, 1989 Inhibition of cytotoxic drug-induced vomiting in Suncus by a ginger constituent. J Ethnopharmacol 27(3):353-355. 54 YAMAHARA J, YAMADA T, KIMURA H, SAWADA T, FUJIMURA H, 1982 Biologically active principles of crude drugs. Anti-allergic principles of "Shoseiryu-To". I. Effect on delayed-type allergy reaction. Yakugaku Zasshi 102(9):881-886. 55 MOWREY DB, CLAYSON DE, 1982 Motion sickness, ginger and psychophysics. Lancet 82(1):655-657. 56 GRONTVED A, BRASK T, KAMBSKARD J, HENTZER E, 1988 Ginger root against seasickness. A controlled trial on the open sea. Acta Otolaryngol (Stockholm) 105(1/2):45-49. 57 HOLTMANN S, CLARKE AH, SCHERER H, HOHN M, 1989 The anti-motion sickness mechanism of ginger. A comparative study with placebo and dimenhydrinate. Acta Otolaryngol (Stockholm) 108(3/4):168-174. 58 WOOD CD, MANNO JE, WOOD MJ, MANNO BR, MIMS ME, 1988 Comparison of efficacy of Ginger with various antimotion sickness drug. Clin Res Pract Drug Reg Affairs 6(2):129-136. 59 FISCHER-RASMUSSEN W, KJAER SK, DAHL C, ASPING U, 1991 Ginger treatment of hyperemesis gravidarum. Eur J Obstetr Gynecol Reprod Biol 38(1):19-24. 60 SRIVASTAVA KC, 1989 Effect of onion and ginger consumption on platelet thromboxane production in humans. Prostaglandins Leukotrienes Essent Fatty Acids 35(3):183-185. 61 BETANCOURT J, MARTINEZ MJ, LOPEZ M, MOREJON Z, BARCELO H, LAINEZ A, MONTES ME, REGO R, BOUCOURT E, MORON F, 2000 Toxicidad aguda clásica de rhizome de Zingiber officinalis Roscoe. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana, Cuba. 62 BETANCOURT J, MARTINEZ MJ, LOPEZ M, MOREJON Z, BOUCOURT E, MORON F, 2000 Actividad genotóxica in vitro de rhizome de Zingiber officinalis Roscoe. Laboratorio Central de Farmacología, Facultad de Ciencias Médicas “Dr. Salvador Allende”, La Habana. 63 CARBALLO A, 1995 Plantas medicinales del Escambray cubano. Informe TRAMIL. Laboratorio provincial de producción de medicamentos, Sancti Spiritus, Cuba. 64 ASWAL BS, BHAKUNI DS, GOEL AK, KAR K, MEHROTRA BN, MUKHERJEE KC, 1984 Screening of Indian plants for biological activity: Part X. Indian J Exp Biol 22(6):312-332. 65 EMIG H, 1931 The pharmacological action of ginger. J Amer Pharm Ass 20:114-116. 66 ANON (Select Committee on GRAS Substances), 1976 GRAS status of foods and food additives. Washington DC, USA: Food and Drug Administration, Department of Health and Human Services, Office of the Federal Register National Archives and Records Administration 41, 38644 67 KUMAZAWA Y, TAKIMOTO H, MIURA SI, NISHIMURA C, YAMADA A, KAWAKITA T, NOMOTO K, 1988 Activation of murine peritoneal macrophages by intraperitoneal administration of a traditional Chinese herbal medicine, Xiao-Chai-Hu-Tang (Japanese name: Shosaiko-To). Int J Inmunopharmacol 10(4):395-403. 68 PERIS JB, STUBING G, 2003 Zingiber officinalis. Vademecum de Fitoterapia, Editorial Masson, Barcelona, España, Jul. 30, 2003. URL: http://www.masson.es/book/fitoterapia.html |